196 related articles for article (PubMed ID: 17111932)
21. CVB infection and mechanisms of viral cardiomyopathy.
Knowlton KU
Curr Top Microbiol Immunol; 2008; 323():315-35. PubMed ID: 18357777
[TBL] [Abstract][Full Text] [Related]
22. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy.
Chapman NM; Kim KS
Curr Top Microbiol Immunol; 2008; 323():275-92. PubMed ID: 18357775
[TBL] [Abstract][Full Text] [Related]
23. [Dilated myocarditis and cardiomyopathies. The dysimmune hypothesis].
Sachs RN
Arch Mal Coeur Vaiss; 1990 Mar; 83(3):407-11. PubMed ID: 2108636
[TBL] [Abstract][Full Text] [Related]
24. [The expression of coxsackie B virus adenovirus receptor (CAR) in viral myocarditis and dilated cardiomyopathy patients].
Li HY; Li YH; Zhu TJ
Fa Yi Xue Za Zhi; 2007 Aug; 23(4):247-9. PubMed ID: 17896511
[TBL] [Abstract][Full Text] [Related]
25. Viral myocarditis.
Rose NR
Curr Opin Rheumatol; 2016 Jul; 28(4):383-9. PubMed ID: 27166925
[TBL] [Abstract][Full Text] [Related]
26. Coxsackievirus B3 infection leads to the generation of cardiac myosin heavy chain-α-reactive CD4 T cells in A/J mice.
Gangaplara A; Massilamany C; Brown DM; Delhon G; Pattnaik AK; Chapman N; Rose N; Steffen D; Reddy J
Clin Immunol; 2012 Sep; 144(3):237-49. PubMed ID: 22854287
[TBL] [Abstract][Full Text] [Related]
27. [Idiopathic dilated cardiomyopathy: a persistent viral infection or an organ-specific autoimmune disease? The trial of 2 major pathogenetic hypotheses].
Caforio AL; Bonifacio E; Keeling PJ; Grazzini M; Schiaffino S; Bottazzo GF; McKenna WJ
G Ital Cardiol; 1992 Jan; 22(1):63-72. PubMed ID: 1624070
[TBL] [Abstract][Full Text] [Related]
28. Pathophysiology of cardiac inflammation: molecular mechanisms.
Pankuweit S; Portig I; Maisch B
Herz; 2002 Nov; 27(7):669-76. PubMed ID: 12439638
[TBL] [Abstract][Full Text] [Related]
29. [Possible relations between viral myocarditis and dilated cardiomyopathy (congestive)].
Goodwin JF
Recenti Prog Med; 1984 Sep; 75(9):833-43. PubMed ID: 6096936
[No Abstract] [Full Text] [Related]
30. Effects of in vivo administration of anti-B7-1/B7-2 monoclonal antibodies on the survival of mice with chronic ongoing myocarditis caused by Coxsackievirus B3.
Seko Y; Takahashi N; Yagita H; Okumura K; Azuma M; Yazaki Y
J Pathol; 1999 May; 188(1):107-12. PubMed ID: 10398149
[TBL] [Abstract][Full Text] [Related]
31. Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy.
Westermann D; Savvatis K; Lindner D; Zietsch C; Becher PM; Hammer E; Heimesaat MM; Bereswill S; Völker U; Escher F; Riad A; Plendl J; Klingel K; Poller W; Schultheiss HP; Tschöpe C
Circulation; 2011 Nov; 124(19):2082-93. PubMed ID: 21986287
[TBL] [Abstract][Full Text] [Related]
32. [The role of Coxsackie B viruses in the etiology of dilated cardiomyopathy].
Novikov IuI; Stulova MA; Lavrova IK
Ter Arkh; 1989; 61(11):97-102. PubMed ID: 2561232
[TBL] [Abstract][Full Text] [Related]
33. Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms.
Lodge PA; Herzum M; Olszewski J; Huber SA
Am J Pathol; 1987 Sep; 128(3):455-63. PubMed ID: 2957924
[TBL] [Abstract][Full Text] [Related]
34. Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy.
Rahnefeld A; Klingel K; Schuermann A; Diny NL; Althof N; Lindner A; Bleienheuft P; Savvatis K; Respondek D; Opitz E; Ketscher L; Sauter M; Seifert U; Tschöpe C; Poller W; Knobeloch KP; Voigt A
Circulation; 2014 Oct; 130(18):1589-600. PubMed ID: 25165091
[TBL] [Abstract][Full Text] [Related]
35. Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity.
Maekawa Y; Ouzounian M; Opavsky MA; Liu PP
Circulation; 2007 Jan; 115(1):5-8. PubMed ID: 17200452
[No Abstract] [Full Text] [Related]
36. [Acute viral myocarditis: new aspects of an old disease].
Gentile R; Gallo P; Laganà B; Vaccaro F
Medicina (Firenze); 1989; 9(3):270-4. PubMed ID: 2693881
[TBL] [Abstract][Full Text] [Related]
37. Molecular biology and pathogenesis of viral myocarditis.
Esfandiarei M; McManus BM
Annu Rev Pathol; 2008; 3():127-55. PubMed ID: 18039131
[TBL] [Abstract][Full Text] [Related]
38. The role of sensitized T-cells in myocarditis and dilated cardiomyopathy.
Schwimmbeck PL; Badorff C; Rohn G; Schulze K; Schultheiss HP
Int J Cardiol; 1996 May; 54(2):117-25. PubMed ID: 8803675
[TBL] [Abstract][Full Text] [Related]
39. Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle.
Yue Y; Xu W; Hu L; Jiang Z; Xiong S
Virology; 2009 Apr; 386(2):438-47. PubMed ID: 19233446
[TBL] [Abstract][Full Text] [Related]
40. Th17 cells facilitate the humoral immune response in patients with acute viral myocarditis.
Yuan J; Cao AL; Yu M; Lin QW; Yu X; Zhang JH; Wang M; Guo HP; Liao YH
J Clin Immunol; 2010 Mar; 30(2):226-34. PubMed ID: 20012175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
